James Mulay, Director at CG Oncology, Inc. (CGON), sold 11,145 shares at $44.16 ($585K) on 2026-01-09, disclosed to the SEC on 2026-01-13.
Open-market sale of $585k CGON by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.16 | 654 | $29K | 4.9% |
| 2 | $52.99 | 10,491 | $556K | 95.1% |
| Total | $52.47 avg | 11,145 | $585K | 100% |
| Filing → |
| CGON | SELL | 2026-04-20 | $1.1M | — | Filing → |
| CGON | SELL | 2026-03-17 | $125K | — | Filing → |
| CGON | SELL | 2025-10-10 | $519K | — | Filing → |